Correlation Analysis and Clinical Significance of Serum LTBP2, COL4A3, CA125 Levels with Clinicopathological Features of Patients with Non-small Cell Lung Cancer

Abstract

Abstract: Objective To investigate the correlation between serum laten transforming growth factor binding protein 2 (LTBP2), type Ⅳ collagen α3 (COL4A3), carbohydrate antigen 125 (CA125) levels and clinicopathological features in patients with non-small cell lung cancer (NSCLC) and their diagnostic value. Methods A total of 97 patients with NSCLC admitted to Zhoukou Central Hospital from May 2021 to May 2023 were included in the observation group, and 97 patients with benign lung lesions were included in the control group. The serum levels of LTBP2 and COL4A3 were measured by double antibody enzyme-linked immunosorbent assay, and the serum levels of CA125 were measured by double antibody sandwich method. The serum levels of the two groups were compared, and the correlation between the levels of each index and pathological characteristics and the diagnostic value of combined detection for NSCLC were analyzed. The correlation between each index level and pathological characteristics was analyzed, as well as the diagnostic value of combined detection in NSCLC. Results Serum LTBP2, COL4A3 and CA125 levels in observation group were higher than those in control group (P<0.05). Serum levels of LTBP2, COL4A3 and CA125 in patients with different TNM stages, depth of invasion and lymph node metastasis were compared: Ⅲ~Ⅳ>Ⅰ~Ⅱ, T3+T4 > T1+T2, with lymph node metastasis > without lymph node metastasis (P<0.05). Serum levels of LTBP2, COL4A3 and CA125 were positively correlated with TNM stage, invasion depth and lymph node metastasis in NSCLC patients. The AUC of all indexes in the combined diagnosis of NSCLC was 0.889, the best sensitivity and specificity were 90.72% and 84.54%, respectively, and the Yoden index was 0.753. Conclusion Serum LTBP2, COL4A3 and CA125 levels are positively correlated with clinicopathological features of patients with NSCLC. Combined detection has certain diagnostic value for NSCLC, and can be used as auxiliary indicators for clinical diagnosis of NSCLC.

Key words: Laten transforming growth factor binding protein 2, Type IV collagen α3;, Carbohydrate antigen 125, Non-small cell lung cancer, Clinicopathological features

摘要： 目的探讨血清转化生长因子结合蛋白2（LTBP2）、Ⅳ型胶原蛋白α3（COL4A3）、糖类抗原125（CA125）水平与非小细胞肺癌（NSCLC）患者临床病理特征的相关性及诊断价值。方法选取2021年5月~2023年5月周口市中心医院收治的NSCLC患者97例,纳入观察组,另选取肺部良性病变患者97例,纳入对照组。采用双抗酶联免疫吸附法测定血清LTBP2、COL4A3,采用双抗体夹心法测定血清CA125水平,比较2组患者血清各指标水平,分析各指标水平与病理特征的相关性及联合检测对NSCLC的诊断价值。结果观察组血清LTBP2、COL4A3、CA125水平高于对照组（P<0.05）;不同TNM分期、浸润深度、淋巴结转移患者血清LTBP2、COL4A3、CA125水平比较：Ⅲ~Ⅳ期>Ⅰ~Ⅱ期、T3+T4>T1+T2、伴有淋巴结转移>无淋巴结转移（P<0.05）;血清LTBP2、COL4A3、CA125水平与NSCLC患者TNM分期、浸润深度、淋巴结转移均呈正相关,且各指标联合诊断NSCLC的AUC为0.889,最佳敏感度、特异度分别为90.72%、84.54%,约登指数为0.753。结论血清LTBP2、COL4A3、CA125水平与NSCLC患者临床病理特征呈正相关,联合检测对NSCLC具有一定诊断价值,可作为临床诊断NSCLC辅助指标。

关键词: 转化生长因子结合蛋白2, Ⅳ型胶原蛋白α3, 糖类抗原125, 非小细胞肺癌, 临床病理特征

CLC Number:

R734.2

YANG Ke, GAO Yuan, SUN Tian-wen, WANG Lin-jing. Correlation Analysis and Clinical Significance of Serum LTBP2, COL4A3, CA125 Levels with Clinicopathological Features of Patients with Non-small Cell Lung Cancer[J]. Journal of Chengde Medical University, 2024, 41(5): 387-391.

杨柯, 高原, 孙天文, 王霖婧. LTBP2、COL4A3、CA125与非小细胞肺癌临床病理特征的相关性及临床意义[J]. 承德医学院学报, 2024, 41(5): 387-391.

Add to citation manager EndNote|Ris|BibTeX

URL: http://tougao.cdmc.edu.cn:8088/EN/

http://tougao.cdmc.edu.cn:8088/EN/Y2024/V41/I5/387

References

[1] 王欣欣,黄松洁,于洋,等. 血清ProGRP、SCCAg及HE4与非小细胞肺癌患者病理特征的关系及其诊断价值分析[J]. 现代生物医学进展,2020,20(13):2497-2501.
[2] 朱瑶瑶,胡敏,徐清华,等. 血清吲哚胺2,3-双加氧酶与早期非小细胞肺癌立体定向放射治疗预后的相关性[J]. 中华放射医学与防护杂志,2020,40(7):512-518.
[3] 王丽娟,席文锦,葛睿,等. 敲低潜在转化生长因子β结合蛋白2(LTBP2)抑制SK-MEL-28恶性黑素瘤细胞的侵袭和迁移[J]. 细胞与分子免疫学杂志,2019,35(2):128-133.
[4] 许学宗,刘培培,金博,等. 血清ANXA2、PDCD5及COL4A3表达水平与肺癌患者临床病理特征及肿瘤转移的相关性[J]. 热带医学杂志,2021,21(2):205-208,封2.
[5] 汪敬群,韩海伟,韩成坤. MRI联合CA125在BOT卵巢癌诊断鉴别中的应用价值[J].中国妇幼保健,2023,38(9):1728-1731.
[6] Ettinger DS, Wood DE, Aisner DL, et al.Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology[J]. J Natl Compr Canc Netw, 2017, 15(4): 504-535.
[7] 徐菊娣,黄骞,杨志勇,等. 卡瑞利珠单抗辅助化疗对中晚期NSCLC患者的近期疗效及对细胞免疫、血清肿瘤标志物的影响[J]. 现代肿瘤医学,2023,31(6):1047-1051.
[8] 何闯,吴蔚,袁晶,等. CT引导下穿刺活检对ⅠA期非小细胞肺癌疾病无进展生存期和总生存期的影响[J]. 介入放射学杂志,2020,29(4):372-375.
[9] 栾宁,刘丹,刘畅,等. LTBP2通过TLR4/NF-κB信号通路抑制糖尿病大鼠海马神经元凋亡[J]. 天津医药,2021,49(8):812-817.
[10] 孙连义,白淑玮,李凤至,等. 潜伏转化生长因子β结合蛋白2(LTBP2)对氧化型低密度脂蛋白诱导的人视网膜色素上皮细胞氧化损伤的影响[J]. 眼科新进展,2021,41(6):540-544.
[11] 叶亚兰,孟凡亮,仰杰. CCL25和LTBP2在非小细胞肺癌患者血清中的表达及在疾病诊断中的应用价值[J]. 临床肺科杂志,2022,27(9):1403-1406,1410.
[12] Yang XT, Wu Q, Wu FY, et al.Differential expression of COL4A3 and collagen in upward and downward progressing types of nasopharyngeal carcinoma[J]. Oncol Lett, 2021, 21(3): 223.
[13] Zheng WZ, Zhang SQ, Guo H, et al.Multi-omics analysis of tumor angiogenesis characteristics and potential epigenetic regulation mechanisms in renal clear cell carcinoma[J]. Cell Commun Signal, 2021, 19(1): 39.
[14] 马海洋,吴琼,张勇. 临床特征联合血清标志物检测预警模型在肺癌骨转移诊断中的临床价值[J]. 中国骨与关节杂志,2023,12(5):351-356.
[15] 刘华,杨培,蒋祥德,等. 吉非替尼对晚期非小细胞肺癌患者化疗中癌胚抗原、CYFRA21-1及CA125表达水平的影响[J]. 临床和实验医学杂志,2022,21(11):1141-1144.